Gene · 23089
Papers1,379
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,379
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Placenta-Related PEG10 Inhibits mRNA Decay to Promote Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. | Cancer Res | 2026 | 42826094 | PubTator, text mining | PubMed |
| Structure-guided antisense oligonucleotides selectively modulate frameshifting of a human gene. | bioRxiv | 2026 | 42818233 | PubTator, text mining | PubMed |
| MicroRNA-122 as a regulator and biomarker of liver disease. | J Mol Med (Berl) | 2026 | 42760391 | PubTator, text mining | PubMed |
| Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer. | Am J Transl Res | 2026 | 42631165 | PubTator, text mining | PubMed |
| Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells. | Front Oncol | 2026 | 42568401 | PubTator, text mining | PubMed |
| Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control. | Tissue Eng Regen Med | 2026 | 42467368 | PubTator, text mining | PubMed |
| Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer. | Cancer Lett | 2026 | 42457019 | PubTator, text mining | PubMed |
| Integrative transcriptomic and CRISPR dependency analysis identifies hepatoblastoma-specific essential genes and actionable vulnerabilities. | Cancer Genet | 2026 | 42385356 | PubTator, text mining | PubMed |
| Hypoxia and lactate metabolism-related gene COL5A3 promotes triple negative breast cancer progression via DDR1/FAK/PI3K/AKT pathway. | Biol Direct | 2026 | 42310796 | PubTator, text mining | PubMed |
| Engineering human PEG10-based nanoparticles for RNA self-packaging, delivery and cancer therapy. | Nat Commun | 2026 | 42285982 | PubTator, text mining | PubMed |
| The retroelement-derived human protein PEG10 is a regulator of mRNA splicing in neurons. | bioRxiv | 2026 | 42239172 | PubTator, text mining | PubMed |
| Integrated analysis of miRNA and transcription factor gene expression profiles associated with anti-tuberculosis treatment responses. | BMC Infect Dis | 2026 | 42237266 | PubTator, text mining | PubMed |
| miR-379-5p promotes ovarian granulosa cell apoptosis in primary ovarian insufficiency by targeting KNDC1 and PEG10. | Front Genet | 2026 | 42205180 | PubTator, text mining | PubMed |
| Polyubiquitination and accumulation of PEG10 regulated by SIAH1/2 affiliates the progression of hepatocellular carcinoma. | Cell Commun Signal | 2026 | 42168988 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental approach identify BRD-family gene DSP as a diagnostic and prognostic indicator in bladder cancer. | Transl Androl Urol | 2026 | 42164400 | PubTator, text mining | PubMed |
| Targeted native long-read sequencing of DNA methylation alterations following CRISPR-Cas9-induced double-strand breaks in human cells. | BMC Res Notes | 2026 | 41808208 | PubTator, text mining | PubMed |
| A retroelement-derived mammalian ARC protein exhibits selective RNA recognition and nucleic acid chaperone functions. | Nucleic Acids Res | 2026 | 41797537 | PubTator, text mining | PubMed |
| Over-expression of Paternally Expressed Gene 10 (PEG10) Is Associated With Poor Prognosis in Upper Tract Urothelial Carcinomas. | Anticancer Res | 2026 | 41760247 | PubTator, text mining | PubMed |
| Effects of 6-months of SSRI use on DNA-methylation and gene expression in blood. | Brain Behav Immun | 2026 | 41759687 | PubTator, text mining | PubMed |
| Diagnostic Value of miR-1225-5p in Acute Coronary Syndrome and its Mechanism in ox-LDL Induced Human Coronary Artery Endothelial Cells Injury. | Clin Appl Thromb Hemost | 2026 | 41757871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23089/papers